Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. - Wikidata - awgldk - TriplyDB

Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up.

Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up.

http://www.wikidata.org/entity/Q47432968

about

Standards of medical care in diabetes--2012 The environment and the origins of islet autoimmunity and Type 1 diabetes Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study Standards of medical care in diabetes--2013 Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease.Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.[Type 1 diabetes and autoimmune polyendocrine syndromes].Standards of medical care in diabetes--2010.Genetic testing of newborns for type 1 diabetes susceptibility: a prospective cohort study on effects on maternal mental health.Banting Lecture 2009: An unfinished journey: molecular pathogenesis to prevention of type 1A diabetes.The Environmental Determinants of Diabetes in the Young (TEDDY) Study.Proficiency testing of human leukocyte antigen-DR and human leukocyte antigen-DQ genetic risk assessment for type 1 diabetes using dried blood spots Reduced morbidity at diagnosis and improved glycemic control in children previously enrolled in DiPiS follow-up.Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY)Standards of medical care in diabetes--2011.Extreme genetic risk for type 1A diabetes Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up.Newborn screening: new developments, new dilemmas.Comparison of Metabolic Outcomes in Children Diagnosed with Type 1 Diabetes Through Research Screening (Diabetes Autoimmunity Study in the Young [DAISY]) Versus in the Community.Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention Dysregulated Toll-like receptor-induced interleukin-1β and interleukin-6 responses in subjects at risk for the development of type 1 diabetes Alternate Ways to Quantify Antibodies.The next big idea.Standards of medical care in diabetes--2009.The natural history of type 1A diabetes.Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset.Feasibility of screening for T1D and celiac disease in a pediatric clinic setting Immunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the future The relationship between BMI and insulin resistance and progression from single to multiple autoantibody positivity and type 1 diabetes among TrialNet Pathway to Prevention participants.Implementing community-based diabetes programs: the scripps whittier diabetes institute experience.Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.Pathogenesis of type 1 diabetes: lessons from natural history studies of high-risk individuals.Building and Validating a Prediction model for Pediatric Type 1 Diabetes Risk Using Next Generation Targeted Sequencing of Class II HLA Genes.Beta-cell specific autoantibodies: Are they just an indicator of type 1 diabetes?Occurrence of type 1 diabetes in graves' disease patients who are positive for antiglutamic Acid decarboxylase antibodies: an 8-year followup study.Patient age, race and the type of diabetes have an impact on the presenting symptoms, latency before diagnosis and laboratory abnormalities at time of diagnosis of diabetes mellitus in children.[Relationship between nutrition factors and glycemic control in children and adolescents with type 1 diabetes mellitus].Factors associated with diabetic ketoacidosis at onset of Type 1 diabetes in children and adolescents.Temporal expression profiling of plasma proteins reveals oxidative stress in early stages of Type 1 Diabetes progression.Ketoacidosis at diagnosis of type 1 diabetes: Effect of prospective studies with newborn genetic screening and follow up of risk children.

P2860

Q24632533-AC1497F6-4BD0-4563-B025-BCBFBE30BBD8 Q26827633-0C87A776-CEEC-4E37-9A0A-ACDA4AD33A45 Q28602447-6A0CFBB4-201B-4D0C-9888-1CB4E535BB78 Q29620309-E39C1D5B-1056-4185-A881-6E068D3D9956 Q30407805-3F3F7D2C-F4BF-4233-829C-E8495A4B834D Q30426632-D04E13B1-E763-4608-B112-421536497862 Q33379406-932FC813-F47A-4E78-9A30-7587360E2299 Q33554238-13B51035-96BF-4263-A2C2-05FE60060982 Q33632761-F2915414-A3BE-4FA0-8F27-A7ECCCC4EB11 Q33750667-06CFFCF3-842A-478E-BDF8-2DFD869B0B12 Q33917733-3E7A5B98-571C-42CB-AA48-AAD600048F0D Q34018140-E924E96E-DACC-4FF3-AFEC-B764799CB9B2 Q34308095-E2FFB931-0E67-4649-9146-837FBF1F5099 Q34355318-BE396066-08B9-4FC3-83B0-FA43A03A9D12 Q34425055-00D48F83-4FBD-413F-BA13-93040DC1ABA8 Q35024527-B18C8514-B64D-410A-AD3E-D6A7425C9B84 Q35408379-5C6767C6-6448-4F4D-8EFB-AB68C8EF9E7E Q35430126-0C229057-2270-4FEB-9598-0C4CDA65A239 Q36014076-945126CB-93A4-42C6-B9C5-9658A2207ECB Q36117948-0A9000AC-F948-4A9E-B79F-23A5FDD85C08 Q36249702-3CD1FC67-D507-45C3-BBB3-6B97F575E071 Q36366700-D451EE4E-B521-4BD0-AEB1-28D030B30991 Q36913144-1254D44D-9E84-4001-8F21-0481BF8AD4A9 Q37036416-7977A790-06C5-48E2-83F7-EB993F5C14F5 Q37148312-B6C70D4F-14C8-4D95-8B7B-8ECA1BFC7464 Q37163792-90F443DD-33DC-4173-8160-D9DCBB37F944 Q37164039-A4FC0185-CA7A-42E7-B7B3-4036B7655F18 Q37364899-CF37C43B-8E5E-431B-9E83-DEF20F82518B Q37368421-61B7A913-808E-4B6A-A033-497670E445FC Q37624463-D3ED5947-05CB-4F23-B105-BF46B8F5CD8C Q37659402-83AFB30F-7408-458E-8A0A-8D052C01851C Q38077588-196F1866-3D4A-4B48-80DD-0DC3F0D85E12 Q38650009-B9A0CA1D-5318-4E10-8DC4-82BC29E6D055 Q38818303-FA699869-417D-49FE-BF54-053B5BC09ECD Q42001671-D1A3E0D4-20B0-427F-BBFA-4353B72E5D31 Q42548158-B4CDC526-5B80-4F89-A21F-54023ADFDC9D Q43045654-F48D3B46-6D81-43C9-98DD-782073F27828 Q44094591-86A83A67-BE34-47C5-AE3F-F833929D26FC Q46290391-3EC4470B-F1FE-4D0E-A1D5-2223CCE0B3CC Q47364345-697B755D-65C8-425B-8CE0-99458F615C31

P2860

Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up.

http://www.wikidata.org/entity/Q47432968

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Clinical characteristics of ch ...... nsive screening and follow-up.

@en

Clinical characteristics of ch ...... nsive screening and follow-up.

@nl

type

label

Clinical characteristics of ch ...... nsive screening and follow-up.

@en

Clinical characteristics of ch ...... nsive screening and follow-up.

@nl

prefLabel

Clinical characteristics of ch ...... nsive screening and follow-up.

@en

Clinical characteristics of ch ...... nsive screening and follow-up.

@nl

P1433

Q47432968-4E7ED09A-FBAF-4916-A0ED-BCF4872DF058

P1476

Q47432968-024B71DD-A25E-4EB9-87BF-09EAA5C00530

P2093

Q47432968-0436A7D1-0A09-4DFD-BC61-53B47A3A51FE

Q47432968-1E3D21B5-8098-4557-B35E-75236F4990E2

Q47432968-2978E089-4BE8-45B3-B2D3-BDE0456F670C

Q47432968-52D3C8FA-E528-4590-9034-FAD48B7215D0

Q47432968-7C7F5825-2325-4E5A-911C-7D5677B3C506

Q47432968-8EE6B5D4-8A5F-4A1D-9553-188E828C61B7

Q47432968-A50431A7-9820-4E13-928A-B74915F2D814

Q47432968-AF28325C-0951-4173-BEF7-CB5F3EB95224

Q47432968-F558912E-7ADA-4590-807E-09F7A533C0D6

P304

Q47432968-FFAFD852-8B9B-4083-8DA7-3D8060BFC64B

P31

Q47432968-103E6BE3-73AD-4422-A94B-F92540977C96

P356

Q47432968-7B6157F5-3C43-464D-9813-DDF63ABFB0B1

P407

Q47432968-D8FC1378-62D2-4957-8FF5-6CE6749F4DED

P433

Q47432968-1787B937-AECE-4280-9169-2EF94A7BBC81

P478

Q47432968-043FB916-198A-43F9-B280-7E9E6194CEB1

P50

Q47432968-FB3D9088-EB42-4565-BBF0-A749735171DB

P577

Q47432968-7BFF3DD5-826E-46B7-9A18-36E5B13CA26B

P5875

Q47432968-2C49AC59-C233-44AA-A564-1897A9688F96

P698

Q47432968-917ABE51-393B-43D9-BF54-6B1C1A68DCD4

P921

Q47432968-9AEF15E6-96A7-4A50-8B05-B47B534E7829

P356

DIACARE.27.6.1399

P1433

P1476

Clinical characteristics of ch ...... nsive screening and follow-up.

@en

P2093

DAISY study

http://www.w3.org/2001/XMLSchema#string

George S Eisenbarth

http://www.w3.org/2001/XMLSchema#string

Georgeanna J Klingensmith

http://www.w3.org/2001/XMLSchema#string

Jennifer M Barker

http://www.w3.org/2001/XMLSchema#string

Jill M Norris

http://www.w3.org/2001/XMLSchema#string

Katherine Barriga

http://www.w3.org/2001/XMLSchema#string

Michelle Hoffman

http://www.w3.org/2001/XMLSchema#string

Robert Slover

http://www.w3.org/2001/XMLSchema#string

Stephanie H Goehrig

http://www.w3.org/2001/XMLSchema#string

P304

1399-1404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DIACARE.27.6.1399

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8544264

http://www.w3.org/2001/XMLSchema#string

P698

15161795

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes